My Cart

Leptin R

Leptin R Overview

English NameLeptin receptorApproved Drugs1
Drugs in Clinical Trials3Target SynonymCD295,OB receptor,LEPR,HuB219,DB,Leptin Receptor,LEP-R,OB-R,OBR,CD295 Antigen,LEPRD,Receptors, Leptin
Highest Development StageApproved
English NameLeptin receptor
Target SynonymCD295,OB receptor,LEPR,HuB219,DB,Leptin Receptor,LEP-R,OB-R,OBR,CD295 Antigen,LEPRD,Receptors, Leptin
Approved Drugs1
Drugs in Clinical Trials3
Highest Development StageApproved

Leptin R Product List

  • Product Category

    Protein (2)

  • Product Status

    Launched (2)

  • Species

    Human (2)

  • Tag

    Fc Tag (1)His Tag & Avi Tag (1)

  • Conjugate

    Unconjugated (1)Biotin-labeled (1)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeatureOrder Now
LER-H5252
Human
HEK293
Human Leptin R / CD295 Protein, Fc Tag
Add to Cart
LER-H82E3
Human
HEK293
Biotinylated Human Leptin R Protein, His,Avitag™
Add to Cart
Total: 2
  • 1

Leptin R Background

Leptin receptor (LEPR) is also known as LEP-R, cluster of differentiation 295 (CD295), OB-R and B219, is a single-transmembrane-domain receptor of the gp130 family of cytokine receptors. Leptin receptor exists as homodimer and binds Leptin with high affinity, thus mediates the biological function of the adipocyte-specific hormone Leptin. LEPR is a receptor for leptin (an adipocyte-specific hormone that regulates body weight), and is involved in the regulation of fat metabolism, as well as in a novel hematopoietic pathway that is required for normal lymphopoiesis. Mutations in this protein have been associated with obesity and pituitary dysfunction. Interaction of leptin and leptin receptor is crucial for body weight and bone mass regulation in mammals through hypothalamic effects on satiety and energy expenditure. Meanwhile, research data supports a leptin receptor activation model based on ligand-induced conformational changes.

Leptin R Synonyms

LEPR,CD295,DKFZp686B1731,OBR,Leptin receptor

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
MibavademabREGN-4461Phase 3 ClinicalRegeneron Pharmaceuticals IncAmenorrhea; Lipodystrophy, Congenital Generalized; Lipodystrophy, Familial Partial; Monogenic obesity; Obesity
Details
RG-6436RG6436; RG-6436Phase 1 ClinicalEnterprise Therapeutics Ltd, Genentech IncUrinary Tract Infections
Details
ERX-1000ERX-1000Phase 1 ClinicalERX Pharmaceuticals IncObesity
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyEarliest Brand NameEarliest Approval CountryEarliest IndicationEarliest Approval CompanyEarliest Approval DateIndicationClinical Trial
MetreleptinKTR-103; AC-164594ApprovedAmylin Pharmaceutical, Astrazeneca Plc, Bristol-Myers Squibb CompanyMetreleptin [SHIONOGI], MyaleptaJapanLipodystrophyShionogi & Co Ltd2013-03-25Diabetes Mellitus; Diabetes Mellitus, Type 1; HIV Infections; Hyperlipidemias; Insulin Resistance; Lipodystrophy; Lipodystrophy, Congenital Generalized; Lipodystrophy, Familial Partial; Metabolic Dysfunction-Associated Steatotic Liver Disease; Metabolic Syndrome; Obesity; Overweight
Details
  • Overview
  • Product List
  • Marketed Drug Information
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland